Moderna : Interim Data From Phase 1 Study Of MRNA Triplet Shows Evidence Of Anti-tumor Activity
13/11 04:43
(RTTNews) - Moderna Inc. (MRNA) presented interim data from an ongoing Phase 1 clinical study of mRNA-2752 (Triplet) in patients with accessible solid tumors and lymphomas....